Drug resistance is a major public health crisis thwarting the effective treatment and care of people living with tuberculosis (TB) – the world’s leading infectious disease killer. But with the release of new curative medicines and ...

Saving more lives with optimal treatment for drug-resistant TB

The 5th edition of “DR-TB Drugs Under the Microscope” chronicles the changing landscape of available treatments for DR-TB, outlines the key barriers to accessing the most effective treatments, and makes recommendations for action that ...

This issue brief analyses access barriers to affordable, lifesaving diagnostics and treatments for HIV and OIs, including adult and paediatric formulations of dolutegravir – a highly effective and tolerable HIV integrase inhibitor that ...

This issue brief examines current opportunities to optimise multidrug-resistant tuberculosis treatment and to address the persistent access challenges that put treatment out of reach for people struggling to survive this deadly disease ...